Biological
Enterovirus 71 vaccine clinical trials
- studies test it
- 12
- open now
- 2
- in phase 3
- 2
- first study started
- 2010
Keep track of what changes. Save the enterovirus 71 vaccine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
12 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 4
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 3
Sinovac Biotech Co., Ltd (8) · Enimmune Corporation (1) · Jiangsu Province Centers for Disease Control and Prevention (1) · National Health Research Institutes, Taiwan (1) · Institute of Medical Biology, Chinese Academy of Medical Sciences (1)
Studies
Open first, then newest update. How each study uses enterovirus 71 vaccine is read from its arms, and is right about nine times in ten.
Testing it · 12
- Bridging Clinical Trial of EV71 Vaccine in Vietnamese ChildrenNot yet recruitingNot applicableSinovac Biotech Co., LtdNCT07793175Written as EV71 vaccine
- Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 VaccineRecruitingPhase 4Institute of Medical Biology, Chinese Academy of Medical SciencesNCT06146088Written as EV71 Vaccine
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and ChildrenCompletedPhase 3Enimmune CorporationNCT05099029Written as EV71 vaccine
- Clinical Trial for Batch Consistency of EV71 VaccineCompletedPhase 4Sinovac Biotech Co., LtdNCT07026500Written as EV71 Vaccine
- Safety and Immunogenicity of EV71 Vaccine With or Without Aluminum Adjuvant in InfantsWithdrawnPhase 2Sinovac Biotech Co., LtdNCT01812135Written as 400 U EV71 vaccine with adjuvant
- Safety of an Inactivated Enterovirus Type 71 Vaccines in Healthy ChildrenCompletedPhase 1Sinovac Biotech Co., LtdNCT01273246Written as 100U inactivated Enterovirus Type 71 Vaccine
- Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71CompletedPhase 4Jiangsu Province Centers for Disease Control and PreventionNCT03582761Written as EV71 vaccine
- Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedPhase 4Sinovac Biotech Co., LtdNCT03278132Written as EV71 vaccine
- A Study to Evaluate the Safety and Immunogenicity of EV71 VaccineCompletedPhase 1National Health Research Institutes, TaiwanNCT01268787Written as EV71 vaccine
- An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedPhase 3Sinovac Biotech Co., LtdNCT01507857Written as 400U /0.5ml EV71 vaccine
- Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy AdultsCompletedPhase 1Sinovac Biotech Co., LtdNCT01273233Written as Inactivated Enterovirus Type 71 Vaccine
- Safety and Immunogenicity of an Inactivated EV71 Vaccine in InfantsCompletedPhase 2Sinovac Biotech Co., LtdNCT01421121Written as 100U EV71 vaccine with adjuvant
As the comparator · 2 — what is tested is compared with enterovirus 71 vaccine
- Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedPhase 4China National Biotec Group Company LimitedNCT04091880Written as EV71 vaccine
- The Phase IVd of Inactivated Enterovirus 71 VaccineStatus unknownPhase 4Chinese Academy of Medical SciencesNCT03296410Written as EV71 vaccine